Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL GARCIA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1245235043
CMS profile
237520
Location
HOUSTON, TX

General Payments · PY2018–2024

$6,566.39

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$307.88

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $307.88 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $139.17 6
Lilly USA, LLC $69.44 4
Amgen Inc. $58.32 3
ABBVIE INC. $20.95 1
SHIELD THERAPEUTICS INC $20.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,946.83 14
PY2019 $1,623.39 14
PY2020 $17.25 1
PY2021 $145.24 4
PY2022 $170.92 10
PY2023 $354.88 19
PY2024 $307.88 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.95 11/14/2024 Food and Beverage Undisputed 01/23/2026 1103773304 CMS
Amgen Inc. $22.64 05/31/2024 Food and Beverage Undisputed 01/23/2026 1117257497 CMS
Amgen Inc. $17.84 08/14/2024 Food and Beverage Undisputed 01/23/2026 1117257499 CMS
Amgen Inc. $17.84 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117257501 CMS
Lilly USA, LLC $17.45 03/01/2024 Food and Beverage Undisputed 01/23/2026 1136108652 CMS
Lilly USA, LLC $16.83 06/21/2024 Food and Beverage Undisputed 01/23/2026 1136115868 CMS
Lilly USA, LLC $16.77 08/22/2024 Food and Beverage Undisputed 01/23/2026 1136115870 CMS
Lilly USA, LLC $18.39 10/24/2024 Food and Beverage Undisputed 01/23/2026 1136116162 CMS
Novo Nordisk Inc $8.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 1097219022 CMS
Novo Nordisk Inc $22.94 02/13/2024 Food and Beverage Undisputed 01/23/2026 1097263871 CMS
Novo Nordisk Inc $23.83 04/15/2024 Food and Beverage Undisputed 01/23/2026 1096748230 CMS
Novo Nordisk Inc $22.66 09/11/2024 Food and Beverage Undisputed 01/23/2026 1096622160 CMS
Novo Nordisk Inc $28.47 10/17/2024 Food and Beverage Undisputed 01/23/2026 1096574805 CMS
Novo Nordisk Inc $32.63 11/04/2024 Food and Beverage Undisputed 01/23/2026 1096889628 CMS
SHIELD THERAPEUTICS INC $20.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 1150154962 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.